Abstract:The consortium of microbes inhabiting the human body, together with their encoded genes and secreted metabolites, is referred to as the “human microbiome.” Several studies have established a link between the composition of the microbiome and its impact on human health. This impact spans local gastrointestinal inflammation to systemic autoimmune disorders and neurodegenerative diseases such as Alzheimer’s and Autism. Some of these links have been validated by rigorous experiments that identify specific strains as mediators or drivers of a particular condition. Consequently, the development of probiotics to compensate for a missing beneficial microbe(s) has advanced and become popular, especially in the treatment of irritable bowel diseases and to restore disrupted gut flora after antibiotic administration. The widespread use of probiotics is often advocated as a natural ecological therapy. However, this perception is not always accurate, as there is a potential for unexpected interactions when administering live microbial cultures. Here, we designed this research to explore the intricate interactions among probiotics, the host, and microbes through a series of experiments. Our objectives included assessing their immunomodulatory effects, response to oral medications, impact on microbial population dynamics, and mediation of antibiotic resistance. To achieve these goals, we employed diverse experimental protocols, including cell-based enzyme -linked immunosorbent assay (ELISA), antibiotic susceptibility testing, antimicrobial activity assays, computational prediction of probiotic genes responsible for antibiotic resistance, polymerase chain reaction (PCR)-based validation of predicted genes, and survival assays of probiotics in the presence of selected oral medications. Our findings highlight that more than half of the tested probiotics trigger an inflammatory response in the Caco-2 cell line, are influenced by oral medications, exhibit antibacterial activity, and possess genes encoding antimicrobial resistance. These results underscore the necessity for a reevaluation of probiotic usage and emphasize the importance of establishing regulations to govern probiotic testing, approval, and administration.

The interplay between probiotics and host autophagy: mechanisms of action and emerging insights

Investigating the Role of Probiotics in Modulating T Cells and the Immune Response: A Systematic Review

Probiotics and gut microbiota: mechanistic insights into gut immune homeostasis through TLR pathway regulation.

The Role of Probiotics in Lipopolysaccharide-Induced Autophagy in Intestinal Epithelial Cells

Autophagy and microbial pathogenesis

From defense to dysfunction: Autophagy's dual role in disease pathophysiology

The Interplay of Host Autophagy and Eukaryotic Pathogens

The Networked Interaction between Probiotics and Intestine in Health and Disease: A Promising Success Story

Targeting gut microbiota and metabolism as the major probiotic mechanism-An evidence-based review

Interactions of Autophagy and the Immune System in Health and Diseases

Probiotics Modulate Host Immune Response and Interact with the Gut Microbiota: Shaping Their Composition and Mediating Antibiotic Resistance

Mechanisms of Probiotic Bacillus Against Enteric Bacterial Infections

Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health

Therapeutic Potential of Autophagy in Immunity and Inflammation: Current and Future Perspectives

Evaluation of the Function of Probiotics, Emphasizing the Role of their Binding to the Intestinal Epithelium in the Stability and their Effects on the Immune System

Anti-oxidative activity of probiotics; focused on cardiovascular disease, cancer, aging, and obesity

Modulation of the Immunity and Inflammation by Autophagy

An Update on the Study of the Molecular Mechanisms Involved in Autophagy during Bacterial Pathogenesis

Probiotics and the microbiota-gut-brain axis in neurodegeneration: Beneficial effects and mechanistic insights

The preventive and therapeutic role of Lactobacillus spp. in in vitro model of inflammation via affecting autophagy signaling pathway

Probiotics and MicroRNA: Their Roles in the Host-Microbe Interactions